These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2818993)

  • 21. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma.
    Moriarty AP; Dowd TC
    Arch Ophthalmol; 1993 Oct; 111(10):1313-4. PubMed ID: 8216000
    [No Abstract]   [Full Text] [Related]  

  • 22. Twelve-hour IOP control obtained by a single dose of timolol/pilocarpine combination eye drops.
    Løfors KT; Høvding G; Viksmoen L; Aasved H; Bergaust B; Bulie T
    Acta Ophthalmol (Copenh); 1990 Jun; 68(3):323-6. PubMed ID: 2203218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
    Stewart WC; Stewart JA; Kapik BM
    J Glaucoma; 1998 Dec; 7(6):388-94. PubMed ID: 9871860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma.
    Konstas AG; Lake S; Maltezos AC; Holmes KT; Stewart WC
    Eye (Lond); 2001 Feb; 15(Pt 1):59-62. PubMed ID: 11318297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.
    Diestelhorst M; Larsson LI;
    Br J Ophthalmol; 2004 Feb; 88(2):199-203. PubMed ID: 14736774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
    Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO
    Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination.
    Sacchi M; Specchia C; Williams SE; Villani E; Nucci P
    Curr Eye Res; 2016 Nov; 41(11):1433-1437. PubMed ID: 27115319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
    Leroy C; Collignon-Brach J
    J Fr Ophtalmol; 1990; 13(1-2):29-32. PubMed ID: 2212504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH; Feldman RM; Sheu WP;
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
    Diestelhorst M; Larsson LI;
    Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
    Seibold LK; DeWitt PE; Kroehl ME; Kahook MY
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):161-169. PubMed ID: 28129020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D; McClellan K
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% administered in the evening in glaucoma.
    Polo V; Larrosa JM; Ferreras A; Borque E; Pablo LE; Honrubia FM
    Ann Ophthalmol (Skokie); 2008; 40(3-4):157-62. PubMed ID: 19230353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol.
    Mesci C; Aydin N; Erbil HH
    J Glaucoma; 2011 Oct; 20(8):477-81. PubMed ID: 21048508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.